Conference paper
THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?
Full text: english pdf 80 Kb
page 435-440
downloads: 345
cite
APA 6th Edition
(2016). THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina, 28 (4), 435-440. Retrieved from https://hrcak.srce.hr/index.php/177179
MLA 8th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina, vol. 28, no. 4, 2016, pp. 435-440. https://hrcak.srce.hr/index.php/177179. Accessed 22 Dec. 2024.
Chicago 17th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina 28, no. 4 (2016): 435-440. https://hrcak.srce.hr/index.php/177179
Harvard
(2016). 'THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?', Psychiatria Danubina, 28(4), pp. 435-440. Available at: https://hrcak.srce.hr/index.php/177179 (Accessed 22 December 2024)
Vancouver
THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina [Internet]. 2016 [cited 2024 December 22];28(4):435-440. Available from: https://hrcak.srce.hr/index.php/177179
IEEE
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?", Psychiatria Danubina, vol.28, no. 4, pp. 435-440, 2016. [Online]. Available: https://hrcak.srce.hr/index.php/177179. [Accessed: 22 December 2024]
Full text: german pdf 80 Kb
page 435-440
downloads: 931
cite
APA 6th Edition
(2016). THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina, 28 (4), 435-440. Retrieved from https://hrcak.srce.hr/index.php/177179
MLA 8th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina, vol. 28, no. 4, 2016, pp. 435-440. https://hrcak.srce.hr/index.php/177179. Accessed 22 Dec. 2024.
Chicago 17th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina 28, no. 4 (2016): 435-440. https://hrcak.srce.hr/index.php/177179
Harvard
(2016). 'THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?', Psychiatria Danubina, 28(4), pp. 435-440. Available at: https://hrcak.srce.hr/index.php/177179 (Accessed 22 December 2024)
Vancouver
THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina [Internet]. 2016 [cited 2024 December 22];28(4):435-440. Available from: https://hrcak.srce.hr/index.php/177179
IEEE
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?", Psychiatria Danubina, vol.28, no. 4, pp. 435-440, 2016. [Online]. Available: https://hrcak.srce.hr/index.php/177179. [Accessed: 22 December 2024]
Abstract
Die Negativsymptomatik hat eine hohe Prävalenz sowohl
in der akuten Episode als auch im langfristigen Verlauf der
Schizophrenie. Sie ist oft persistierend und neigt zur Chronifizierung.
Sie hat wichtige negative Auswirkungen auf die verschiedenen
Dimensionen des Krankheitsausgangs und erfordert
daher eine sorgfältige Diagnose und Behandlung. Die
Evidenzlage für die verfügbaren psychopharmakologischen
Behandlungen ist jedoch noch nicht zufriedenstellend und
weitere Forschung ist notwendig.
Antipsychotika, vor allem einige Antipsychotika der zweiten
Generation, sind die bevorzugte Behandlung der Wahl, vor
allem bei der Negativsymptomatik der akuten Episode. Bei
einem schizophrenen Residuum ist eine gleichzeitige Behandlung
mit Antidepressiva oft angezeigt. Glutamaterge Präparate
sind von großem theoretischen Interesse als Add-on-
Behandlung oder sogar als Monotherapie, aber die
Wirksamkeitsergebnisse sind bisher inkonsistent und ihre
klinische Anwendung ist begrenzt.
Keywords
Negativsymptomatik; Schizophrenie; Antipsychotika; Antidepressiva; glutamaterge Präparate
Hrčak ID:
177179
URI
https://hrcak.srce.hr/177179
Publication date:
12.12.2016.
Article data in other languages:
english
Visits: 2.022
*
